Abstracts Archive - Page 436 of 1683 - ATC Abstracts

2020 American Transplant Congress
Public Information Needs about VCA Donation and Transplantation in the United States
H. Sung¹, A. Ferzola¹, J. Uriarte², N. Anderson², C. Cooney¹, G. Brandacher¹, E. Gordon², M. Henderson¹
¹Johns Hopkins University, Baltimore, MD, ²Northwestern University, Evanston, IL
*Purpose: Vascularized Composite Allotransplantation (VCA) involves transplantation of multiple tissues (e.g., skin, muscle, bone, nerves, blood vessels, etc.) as a structural unit from a donor…
2020 American Transplant Congress
Stem Cell and Novel Neurotrophic Factors to Promote Functional Outcomes in Limb Transplantation
S. K. Salgar, J. Weiss, C. Phillips, E. Malin, V. Gorantla, J. Harding
Clinical Investigation, Madigan Army Medical Center, Tacoma, WA
*Purpose: Recently, transplantation of hand and face has become a new clinical specialty. The objective of this study was to determine whether adult Mesenchymal Stem…
2020 American Transplant Congress
Pre-Transplant Pharmacogenetics Identifies CYP3A4 and CYP3A5 Heterogeneity among Caucasian Kidney Transplant Recipients
N. Oliver¹, L. Lindberg¹, S. LeCorchick¹, D. Morris¹, S. Anand¹, T. Srinivas²
¹Intermountain Medical Center, Murray, UT, ²University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Tacrolimus has always been dosed based on therapeutic drug monitoring, however pharmacogenomics is becoming increasingly more utilized in the era of precision based medicine…
2020 American Transplant Congress
Single Center Experience with Allograft Pancreatectomy
V. Gurram, A. Farney, J. Rogers, G. Orlando, C. Jay, R. Stratta, D. Harriman
Abdominal Transplant Surgery, Wake Forest Baptist Health, Winston Salem, NC
*Purpose: Limited data on indications for and outcomes following allograft pancreatectomy (AP) exist. The purpose of this study was to analyze our single center experience…
2020 American Transplant Congress
Pancreas Transplant in Chronic Kidney Disease for Type 1 Diabetic Patients
R. A. Choudhury, D. Yoeli, H. B. Moore, H. Yaffe, K. D. Conzen, T. L. Nydam, P. T. Kennealey
Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO
*Purpose: Although both pancreas transplantation alone (PTA) and islet cell transplantation (ICT) have been associated with peri-operative declines in eGFR, the magnitude of decline is…
2020 American Transplant Congress
Pancreas Transplants in Asian Recipients
A. Gruessner, C. Gruessner, S. Saggi, J. Renz
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Over the years, a change in patients receiving a pancreas transplant could be observed. While in the beginning the standard pancreas transplant recipient was…
2020 American Transplant Congress
Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation
A. Montal, J. Torabi, N. Muhdi, J. Melvin, Y. Miura, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, S. Greenstein, J. P. Rocca, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: The use of kidneys with high terminal creatinine has been demonstrated in renal transplantation with excellent outcomes. Here we explore the use of high…
2020 American Transplant Congress
A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience
Y. Cui, M. F. Wang, C. C. Wei, J. Y. Wu
Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
*Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…
2020 American Transplant Congress
Effect of Increased Recipient Age on Solid-Organ Pancreas Transplantation Outcomes: A Systematic Review
J. E. Ling
Nephrology, Monash Medical Centre, Clayton, Australia
*Purpose: Increased recipient age has been associated with poorer solid organ pancreas transplant (SOPTx) outcomes. We hypothesized that recipient age cut-offs in Australia and New…
2020 American Transplant Congress
Pancreas Transplant in Patients Older Than 50: An Analysis of Outcomes and Immunosuppression
I. Booth¹, J. Casale¹, S. Freedman¹, B. Ravichandran¹, J. Scalea², A. Haririan², B. Masters¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Medicine, University of Maryland Medical Center, Baltimore, MD
*Purpose: Pancreas transplant (PT) is the ideal therapy for many patients with diabetes and kidney failure. There are limited published data addressing the impact of…